Later, it was discovered that both the m6A level and METTL3 expression were increased in the livers of patients with type 2 diabetes mellitus (T2DM), and their expression was positively associated with IR by promoting the expression of fatty acid synthase (Fasn) (110). The gene discussed is METTL3; the disease is type 2 diabetes mellitus.